Does Wrapping With Bone Marrow Injection Enhance Healing of Meniscal Sutures Into the Avascular Area
1 other identifier
interventional
96
1 country
2
Brief Summary
This study will compare meniscal healing of non-vascularised area augmented or not by bone marrow injected under a protective collagen membrane (meniscal wrapping)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2017
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 18, 2017
CompletedFirst Submitted
Initial submission to the registry
May 10, 2019
CompletedFirst Posted
Study publicly available on registry
May 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 19, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMarch 11, 2026
March 1, 2026
7.7 years
May 10, 2019
March 10, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Change in integrity and healing of meniscus repair
Arthrography (arthro-CT)
12 and 24 months after treatment
Knee injury and Osteoarthritis Outcome Score (KOOS)
Changes in the 5 subscales of KOOS as assessed from baseline to 24 months post-surgery
baseline and 3, 12 and 24 months after treatment
International Knee Documentation Committee Score (IKDC)
Change in physical pain and function as assessed by IKDC score from baseline to 24 months post-surgery
baseline and 3, 12 and 24 months after treatment
SF-12 Survey
Change in functional health and well-being as assessed by SF-12 Survey from baseline to 24 months post-surgery
baseline and 3, 12 and 24 months after treatment
Failure rate
Number of readmission for meniscus tear
up to 24 months
Secondary Outcomes (2)
Change in integrity of meniscus and adjacent tissues (cartilage, bone, synovial tissue)
12 months after treatment
Rate of suture type-associated complications
up to 24 months
Study Arms (2)
Suturing meniscal augmented
EXPERIMENTALNon-vascularised area meniscus tear was sutured and bone marrow was injected under a protective collagen membrane (ChondroGide)
Suturing meniscal
ACTIVE COMPARATORNon-vascularised area meniscus tear was only sutured
Interventions
meniscal tear sutured + bone marrow injection/collagen membrane
Eligibility Criteria
You may qualify if:
- Symptomatic or traumatic tears of medial or lateral meniscus;
- Tearing affecting: only 2/3 central (= avascular zone) over more than 1 cm OR extending from the peripheral third (= vascularized area) within the avascular zone over more than 1 cm. In this case, preservation of the peripheral third over a width of at least 4 mm from the capsule;
- Single or multiple tears.
You may not qualify if:
- Meniscal tears that can not be sutured, reduced / approximated
- Tear creating a meniscal root avulsion
- Partial meniscal tears
- Meniscal tears already sutured
- Cartilage damage in the compartment\> grade 2 (ICRS classification)
- Mechanical axis (varus / valgus) ≥ 2 °
- Untreated ligament deficiency
- Osteotomy and / or concomitant ligament reconstruction, with the exception of ACL reconstruction.
- Compromised general health condition (score ASA score\> 2)
- BMI ≥30
- Active smoking, drug use
- Allergy to porcine collagen
- Poor compliance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Centre Hospitalier Universitaire Vaudois - CHUV
Lausanne, Canton of Vaud, 1011, Switzerland
Dr Robin MARTIN
Lausanne, Canton of Vaud, 1011, Switzerland
Study Officials
- PRINCIPAL INVESTIGATOR
Robin MARTIN, MD
Centre Hospitalier Universitaire Vaudois
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 10, 2019
First Posted
May 30, 2019
Study Start
July 18, 2017
Primary Completion
March 19, 2025
Study Completion
December 31, 2025
Last Updated
March 11, 2026
Record last verified: 2026-03